Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innovate (VATE) Cash & Equivalents (2016 - 2025)

Innovate has reported Cash & Equivalents over the past 16 years, most recently at $112.1 million for Q4 2025.

  • Quarterly results put Cash & Equivalents at $112.1 million for Q4 2025, up 129.71% from a year ago — trailing twelve months through Dec 2025 was $112.1 million (up 129.71% YoY), and the annual figure for FY2025 was $112.1 million, up 129.71%.
  • Cash & Equivalents for Q4 2025 was $112.1 million at Innovate, up from $35.5 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for VATE hit a ceiling of $112.1 million in Q4 2025 and a floor of $16.6 million in Q1 2023.
  • Median Cash & Equivalents over the past 5 years was $41.9 million (2021), compared with a mean of $47.3 million.
  • Biggest five-year swings in Cash & Equivalents: soared 263.76% in 2021 and later plummeted 58.35% in 2025.
  • Innovate's Cash & Equivalents stood at $45.5 million in 2021, then skyrocketed by 76.7% to $80.4 million in 2022, then increased by 0.5% to $80.8 million in 2023, then tumbled by 39.6% to $48.8 million in 2024, then soared by 129.71% to $112.1 million in 2025.
  • The last three reported values for Cash & Equivalents were $112.1 million (Q4 2025), $35.5 million (Q3 2025), and $33.4 million (Q2 2025) per Business Quant data.